These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33316275)

  • 1. Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Kazemi M; Kim JY; Parry SA; Azziz R; Lujan ME
    Am J Obstet Gynecol; 2021 May; 224(5):428-444.e8. PubMed ID: 33316275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive evaluation of disparities in cardiometabolic and reproductive risk between Hispanic and White women with polycystic ovary syndrome in the United States: a systematic review and meta-analysis.
    Kazemi M; Kim JY; Wan C; Xiong JD; Parry SA; Azziz R; Lujan ME
    Am J Obstet Gynecol; 2022 Feb; 226(2):187-204.e15. PubMed ID: 34384776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Dietary Glycemic Index and Glycemic Load on Cardiometabolic and Reproductive Profiles in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Kazemi M; Hadi A; Pierson RA; Lujan ME; Zello GA; Chilibeck PD
    Adv Nutr; 2021 Feb; 12(1):161-178. PubMed ID: 32805007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
    Wekker V; van Dammen L; Koning A; Heida KY; Painter RC; Limpens J; Laven JSE; Roeters van Lennep JE; Roseboom TJ; Hoek A
    Hum Reprod Update; 2020 Nov; 26(6):942-960. PubMed ID: 32995872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis.
    Gunning MN; Sir Petermann T; Crisosto N; van Rijn BB; de Wilde MA; Christ JP; Uiterwaal CSPM; de Jager W; Eijkemans MJC; Kunselman AR; Legro RS; Fauser BCJM
    Hum Reprod Update; 2020 Jan; 26(1):103-117. PubMed ID: 31867675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher high-density lipoprotein cholesterol in African-American women with polycystic ovary syndrome compared with Caucasian counterparts.
    Koval KW; Setji TL; Reyes E; Brown AJ
    J Clin Endocrinol Metab; 2010 Sep; 95(9):E49-53. PubMed ID: 20534766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.
    Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A
    Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome.
    Marchesan LB; Spritzer PM
    Fertil Steril; 2019 Mar; 111(3):579-587.e1. PubMed ID: 30827526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study.
    Chen W; Srinivasan SR; Elkasabany A; Berenson GS
    Am J Epidemiol; 1999 Oct; 150(7):667-74. PubMed ID: 10512420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of dietary and physical activity behaviors in women with and without polycystic ovary syndrome: a systematic review and meta-analysis of 39 471 women.
    Kazemi M; Kim JY; Wan C; Xiong JD; Michalak J; Xavier IB; Ganga K; Tay CT; Grieger JA; Parry SA; Moran LJ; Lujan ME
    Hum Reprod Update; 2022 Nov; 28(6):910-955. PubMed ID: 35639552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome.
    Legro RS; Kunselman AR; Dunaif A
    Am J Med; 2001 Dec; 111(8):607-13. PubMed ID: 11755503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in body composition and cardiometabolic risk during the menopause transition: a prospective, observational cohort study.
    Marlatt KL; Redman LM; Beyl RA; Smith SR; Champagne CM; Yi F; Lovejoy JC
    Am J Obstet Gynecol; 2020 Apr; 222(4):365.e1-365.e18. PubMed ID: 31610152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population.
    Glueck CJ; Morrison JA; Goldenberg N; Wang P
    Metabolism; 2009 May; 58(5):714-21. PubMed ID: 19375597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.
    Gaillard TR; Schuster DP; Bossetti BM; Green PA; Osei K
    Diabetes Care; 1997 May; 20(5):745-52. PubMed ID: 9135936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome in obesity: treatment success and adverse pregnancy outcomes with ovulation induction in polycystic ovary syndrome.
    Arya S; Hansen KR; Peck JD; Wild RA;
    Am J Obstet Gynecol; 2021 Sep; 225(3):280.e1-280.e11. PubMed ID: 33852887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies.
    Halperin IJ; Kumar SS; Stroup DF; Laredo SE
    Hum Reprod; 2011 Jan; 26(1):191-201. PubMed ID: 21059754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.